MAM
NWBOW

Majedie Asset Management’s Northwest Biotherapeutics, Inc. NWBOW Stock Holding History

Majedie Asset Management’s Portfolio NWBOW Stock Details NWBOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-103,380
Closed – – 51
2014
Q1 		$0 Hold
103,380
– – ﹤0.01% 14
2013
Q4 		$0 Buy
+103,380
New +$276K ﹤0.01% 13

Other funds holding NWBOW

Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Majedie Asset Management's NWBOW Position: Q2 2014 in Review

Majedie Asset Management sold out of Northwest Biotherapeutics, Inc. (NWBOW) in Q2 2014, closing a stake of 103,380 shares.

Majedie Asset Management first reported a position in NWBOW in Q4 2013 and held it in 2 quarters. The position peaked at $0 in Q1 2014. 4 funds tracked by Wall St. Rank hold NWBOW as of Q2 2014.

  • Majedie Asset Management reported no remaining Northwest Biotherapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
  • Majedie Asset Management sold 103,380 Northwest Biotherapeutics, Inc. shares in Q2 2014.
  • Majedie Asset Management first reported a position in Northwest Biotherapeutics, Inc. in Q4 2013 and held it in 2 quarters.
  • Majedie Asset Management's Northwest Biotherapeutics, Inc. position peaked at $0 in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. as of Q2 2014.

Based on Majedie Asset Management's 13F filing for Q2 2014, filed 1 Aug 2014.